{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:27:12Z","timestamp":1772890032711,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pharep.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:58:35Z","timestamp":1550231915000},"page":"517-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Inhibitory effects of sildenafil and tadalafil on inflammation, oxidative stress and nitrosative stress in animal model of bronchial asthma"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-8617","authenticated-orcid":false,"given":"Vijaya","family":"Laxmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapan K.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunabha","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2019.02.008_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.pharep.2019.02.008_bib0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharep.2019.02.008_bib0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharep.2019.02.008_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Fan Chung","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2019.02.008_bib0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/COPD.S1761","article-title":"ABCD of the phosphodiesterase family: interaction and differential activity in COPD","volume":"3","author":"Halpin","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharep.2019.02.008_bib0035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrd893","article-title":"Phosphodiesterase 5 inhibitors: current status and potential applications","volume":"1","author":"Rotella","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharep.2019.02.008_bib0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharep.2019.02.008_bib0045","first-page":"399","article-title":"Multiple cyclic nucleotide phosphodiesterases","volume":"46","author":"Beavo","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0007-0971(83)90009-8","article-title":"Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M & B 22,948)","volume":"77","author":"Rudd","year":"1983","journal-title":"Br J Dis Chest"},{"issue":"Suppl 1","key":"10.1016\/j.pharep.2019.02.008_bib0055","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1038\/sj.bjp.0706495","article-title":"Phosphodiesterase inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1139\/cjpp-2013-0316","article-title":"Vardenafil ameliorates immunologic- and non-immunologic-induced allergic reactions","volume":"92","author":"El-Awady","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1183\/09031936.00055908","article-title":"Effect of sildenafil on acrolein-induced airway inflammation and mucus production in rats","volume":"33","author":"Wang","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharep.2019.02.008_bib0070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.burns.2012.12.017","article-title":"The protective effects of sildenafil in acute lung injury in a rat model of severe scald burn: a biochemical and histopathological study","volume":"39","author":"Gokakin","year":"2013","journal-title":"Burns"},{"key":"10.1016\/j.pharep.2019.02.008_bib0075","doi-asserted-by":"crossref","first-page":"L401","DOI":"10.1152\/ajplung.00027.2009","article-title":"Animal models of asthma","volume":"297","author":"Bates","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0080","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.biopha.2017.08.017","article-title":"Ameliorative effects of Artemisia pallens in a murine model of ovalbumin-induced allergic asthma via modulation of biochemical perturbations","volume":"94","author":"Mukherjee","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2019.02.008_bib0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.taap.2016.06.026","article-title":"Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model","volume":"306","author":"Dhawale","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0090","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.bjp.0701875","article-title":"Impairment in connective tissue mast cells degranulation in spontaneously hypertensive rats: stimulus dependent resistance","volume":"124","author":"Kwasniewski","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jep.2006.09.019","article-title":"Effect of Catha edulis foresk (khat) extracts on male rat sexual behavior","volume":"110","author":"Abdulwaheb","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1164\/rccm.200211-1372OC","article-title":"Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease","volume":"169","author":"Toward","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharep.2019.02.008_bib0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.17305\/bjbms.2011.2567","article-title":"The effects of tadalafil on renal ischemia reperfusion injury: an experimental study","volume":"11","author":"Gasanov","year":"2011","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.pharep.2019.02.008_bib0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2013.01.031","article-title":"Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia\/reperfusion injury in type 2 diabetic mice","volume":"60","author":"Koka","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharep.2019.02.008_bib0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharep.2019.02.008_bib0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharep.2019.02.008_bib0125","first-page":"1295","article-title":"The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat","volume":"273","author":"Tracey","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"10.1016\/j.pharep.2019.02.008_bib0130","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1513\/AnnalsATS.201506-385MG","article-title":"New insights in oxidant biology in asthma","volume":"13","author":"Erzurum","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.pharep.2019.02.008_bib0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.intimp.2016.10.007","article-title":"Tadalafil reduces airway hyperactivity and protects against lung and respiratory airways dysfunction in a rat model of silicosis","volume":"40","author":"Abdelaziz","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0140","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1440-1746.2009.05797.x","article-title":"The effect of sildenafil, a phosphodiesterase-5 inhibitor, on acetic acid-induced colonic inflammation in the rat","volume":"24","author":"Iseri","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.redox.2015.11.009","article-title":"Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability","volume":"7","author":"Semen","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0150","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1476-5381.1981.tb08748.x","article-title":"Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction","volume":"73","author":"Frossard","year":"1981","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0155","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery","volume":"175","author":"Andersson","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2019.02.008_bib0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.trsl.2009.01.008","article-title":"Atherogenic dyslipidemia and oxidative stress: a new look","volume":"153","author":"Rizzo","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.pharep.2019.02.008_bib0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.RES.0000091074.33584.F0","article-title":"Role of phosphodiesterase 3 in NO\/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells","volume":"93","author":"Aizawa","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharep.2019.02.008_bib0170","doi-asserted-by":"crossref","first-page":"30969","DOI":"10.1074\/jbc.272.49.30969","article-title":"Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha","volume":"272","author":"Spiecker","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2019.02.008_bib0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12950-015-0099-7","article-title":"The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review","volume":"12","author":"Peixoto","year":"2015","journal-title":"J Inflamm (Lond)"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:55Z","timestamp":1752611875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2019.02.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1734114018303487"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2019.02.008","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of sildenafil and tadalafil on inflammation, oxidative stress and nitrosative stress in animal model of bronchial asthma","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}